Patent details
EP2924034
Title:
PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP2924034
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP15157348.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
300981
First Applicant Residence Country:
Canada (CA)
Publications:
Dates
Filing date:
28/03/2011
Grant date:
02/11/2016
EP Publication Date:
30/09/2015
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
25/01/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
02/11/2016
EP B1 Publication Date:
02/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
27/03/2031
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
02/11/2016
Name:
Merck Canada Inc.
Address:
16711 Trans-Canada Highway, KIRKLAND QC H9H 3L1, Canada (CA)
Domicile Holder
Name:
ir. H.A. Witmans c.s.
From:
25/01/2017
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Inventor
1
Name:
Burch, Jason
Address:
Redwood City, CA California 94062, United States of America (US)
2
Name:
Cote, Bernard
Address:
Notre-Dame-de-l'll-Perrot, Québec J7V 7P2, Canada (CA)
Priority
1
Priority Patent Number:
321573 P
Priority Date:
07/04/2010
Priority Country:
United States of America (US)
2
Priority Patent Number:
318824 P
Priority Date:
30/03/2010
Priority Country:
United States of America (US)
Classification
IPC or IDT classification:
A61K 31/4439 ;
A61P 31/18 ;
C07D 401/06 ;
Publication
Bulletin
1
Bulletin Heading:
EP3
Journal edition number:
06/17
Publication date:
08/02/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
2
Bulletin Heading:
EP2
Journal edition number:
44/16
Publication date:
07/11/2016
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
201644
Publication date:
02/11/2016
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
31/03/2027
Annual Fee Number:
17
Annual Fee Amount:
1100 Euro
Last Annual Payment Date:
11/02/2026
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Master Data Center
Filing date
Document type
Document Description
Number of pages
File Type
02/02/2017
Outgoing Correspondence
Letter no formal defects
1
PDF
/3/2/6/3/0/0800103623/docs/ep15157348.2_4_115061l271.pdf
25/01/2017
Claims
First filed claims
2
PDF
/3/2/6/3/0/0800103623/docs/ep15157348.2_0_claims20170125150859785.pdf
25/01/2017
Incoming Correspondence Electronic
Accompanying letter incoming document
2
PDF
/3/2/6/3/0/0800103623/docs/ep15157348.2_1_incomingcorrespondenceelectronic20170125150900973.pdf
25/01/2017
Incoming Correspondence Electronic
Accompanying letter incoming document
1
PDF
/3/2/6/3/0/0800103623/docs/ep15157348.2_2_incomingcorrespondenceelectronic20170125180815296.pdf
25/01/2017
Incoming Correspondence Electronic
Correspondence address details
1
PDF
/3/2/6/3/0/0800103623/docs/ep15157348.2_3_incomingcorrespondenceelectronic20170125180814589.pdf